COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952924006281 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841560511572869120 |
|---|---|
| author | Francesco Autore Andrea Visentin Marina Deodato Candida Vitale Eugenio Galli Alberto Fresa Rita Fazzi Alessandro Sanna Jacopo Olivieri Ilaria Scortechini Maria Ilaria Del Principe Paolo Sportoletti Idanna Innocenti Marta Coscia Alessandra Tedeschi Livio Trentin Anna Candoni Alessandro Busca Livio Pagano Luca Laurenti |
| author_facet | Francesco Autore Andrea Visentin Marina Deodato Candida Vitale Eugenio Galli Alberto Fresa Rita Fazzi Alessandro Sanna Jacopo Olivieri Ilaria Scortechini Maria Ilaria Del Principe Paolo Sportoletti Idanna Innocenti Marta Coscia Alessandra Tedeschi Livio Trentin Anna Candoni Alessandro Busca Livio Pagano Luca Laurenti |
| author_sort | Francesco Autore |
| collection | DOAJ |
| format | Article |
| id | doaj-art-c1e185418859416899460d28fdc6ec31 |
| institution | Kabale University |
| issn | 2473-9529 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Blood Advances |
| spelling | doaj-art-c1e185418859416899460d28fdc6ec312025-01-04T04:56:46ZengElsevierBlood Advances2473-95292025-01-0191162165COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?Francesco Autore0Andrea Visentin1Marina Deodato2Candida Vitale3Eugenio Galli4Alberto Fresa5Rita Fazzi6Alessandro Sanna7Jacopo Olivieri8Ilaria Scortechini9Maria Ilaria Del Principe10Paolo Sportoletti11Idanna Innocenti12Marta Coscia13Alessandra Tedeschi14Livio Trentin15Anna Candoni16Alessandro Busca17Livio Pagano18Luca Laurenti19Dipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Correspondence: Francesco Autore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, I-00168 Rome, Italy;Department of Medicine, Hematology Unit, Università degli Studi di Padova, Padova, ItalyDivision of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, ItalyDivision of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, ItalyDipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyU.O. Ematologia, Azienda Ospedaliera Universitaria Pisana, Pisa, ItalyHematology Unit, Department of Oncology, Azienda Ospedaliera Universitaria di Careggi, Florence, ItalyClinica Ematologia di Udine, Azienda Sanitaria Universitaria Friuli Centrale, Udine, ItalyClinica di Ematologia, Azienda ospedaliero Universitaria delle Marche, Ancona, ItalyDipartimento di Biomedicina e Prevenzione, Università degli studi di Roma Tor Vergata, Rome, ItalyDepartment of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncology Research (CREO), University of Perugia, A.O. Santa Maria della Misericordia di Perugia, Perugia, ItalyDipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, ItalyDivision of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, ItalyDivision of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, ItalyDepartment of Medicine, Hematology Unit, Università degli Studi di Padova, Padova, ItalySection of Haematology, Dept. of Medical and Surgical Sciences, Università degli Studi di Modena e Reggio Emilia, Modena, ItalyDivision of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, ItalyDipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica, ed Ematologia, Università Cattolica del Sacro Cuore, Rome, ItalyDipartimento di Scienze di Laboratorio ed Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica, ed Ematologia, Università Cattolica del Sacro Cuore, Rome, Italyhttp://www.sciencedirect.com/science/article/pii/S2473952924006281 |
| spellingShingle | Francesco Autore Andrea Visentin Marina Deodato Candida Vitale Eugenio Galli Alberto Fresa Rita Fazzi Alessandro Sanna Jacopo Olivieri Ilaria Scortechini Maria Ilaria Del Principe Paolo Sportoletti Idanna Innocenti Marta Coscia Alessandra Tedeschi Livio Trentin Anna Candoni Alessandro Busca Livio Pagano Luca Laurenti COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody? Blood Advances |
| title | COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody? |
| title_full | COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody? |
| title_fullStr | COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody? |
| title_full_unstemmed | COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody? |
| title_short | COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody? |
| title_sort | covid 19 in patients with chronic lymphocytic leukemia treated with venetoclax what is the role of anti cd20 antibody |
| url | http://www.sciencedirect.com/science/article/pii/S2473952924006281 |
| work_keys_str_mv | AT francescoautore covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT andreavisentin covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT marinadeodato covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT candidavitale covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT eugeniogalli covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT albertofresa covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT ritafazzi covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT alessandrosanna covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT jacopoolivieri covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT ilariascortechini covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT mariailariadelprincipe covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT paolosportoletti covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT idannainnocenti covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT martacoscia covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT alessandratedeschi covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT liviotrentin covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT annacandoni covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT alessandrobusca covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT liviopagano covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody AT lucalaurenti covid19inpatientswithchroniclymphocyticleukemiatreatedwithvenetoclaxwhatistheroleofanticd20antibody |